2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

作者: Stephan Windecker , Philippe Kolh , Fernando Alfonso , Jean-Philippe Collet , Jochen Cremer

DOI: 10.1093/EJCTS/EZU366

关键词:

摘要:

参考文章(989)
Ran Kornowski, Roxana Mehran, George Dangas, Eugenia Nikolsky, Abid Assali, Bimmer E Claessen, Bernard J Gersh, S Chiu Wong, Bernhard Witzenbichler, Giulio Guagliumi, Dariusz Dudek, Martin Fahy, Alexandra J Lansky, Gregg W Stone, HORIZONS-AMI Trial Investigators, Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction : Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial Journal of the American College of Cardiology. ,vol. 58, pp. 704- 711 ,(2011) , 10.1016/J.JACC.2011.02.071
Brian A. Mc Ardle, Taylor F. Dowsley, Robert A. deKemp, George A. Wells, Rob S. Beanlands, Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. Journal of the American College of Cardiology. ,vol. 60, pp. 1828- 1837 ,(2012) , 10.1016/J.JACC.2012.07.038
Rob SB Beanlands, Graham Nichol, Ella Huszti, Dennis Humen, Normand Racine, Michael Freeman, Karen Y Gulenchyn, Linda Garrard, Robert dekemp, Ann Guo, Terrence D Ruddy, Francois Benard, André Lamy, Robert M Iwanochko, PARR-2 Investigators‡‡, F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). Journal of the American College of Cardiology. ,vol. 50, pp. 2002- 2012 ,(2007) , 10.1016/J.JACC.2007.09.006
George D. Dangas, Patrick W. Serruys, Dean J. Kereiakes, James Hermiller, Ali Rizvi, William Newman, Krishnankutty Sudhir, Robert S. Smith, Sherry Cao, Kleanthis Theodoropoulos, Donald E. Cutlip, Alexandra J. Lansky, Gregg W. Stone, Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Jacc-cardiovascular Interventions. ,vol. 6, pp. 914- 922 ,(2013) , 10.1016/J.JCIN.2013.05.005
Azeem Latib, Antonio Colombo, Bifurcation Disease JACC: Cardiovascular Interventions. ,vol. 1, pp. 218- 226 ,(2008) , 10.1016/J.JCIN.2007.12.008
Kiran R. Nandalur, Ben A. Dwamena, Asim F. Choudhri, Mohan R. Nandalur, Ruth C. Carlos, Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. Journal of the American College of Cardiology. ,vol. 50, pp. 1343- 1353 ,(2007) , 10.1016/J.JACC.2007.06.030
M Ho, K Hirano, T Inoue, T Akimoto, R Tsukahara, T Muramatsu, S Ito, Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. Journal of Invasive Cardiology. ,vol. 11, pp. 201- 206 ,(1999)
Emmanouil S. Brilakis, John M. Lasala, David A. Cox, Peter B. Berger, Thomas S. Bowman, Ruth M. Starzyk, Keith D. Dawkins, Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program. Jacc-cardiovascular Interventions. ,vol. 3, pp. 742- 750 ,(2010) , 10.1016/J.JCIN.2010.04.012
Tsutomu Takagi, Hiroyuki Okura, Yoshiki Kobayashi, Toru Kataoka, Haruyuki Taguchi, Iku Toda, Koichi Tamita, Atsushi Yamamuro, Yuji Sakanoue, Akira Ito, Shiro Yanagi, Kenji Shimeno, Katsuhisa Waseda, Masao Yamasaki, Peter J. Fitzgerald, Fumiaki Ikeno, Yasuhiro Honda, Minoru Yoshiyama, Junichi Yoshikawa, A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes JACC: Cardiovascular Interventions. ,vol. 2, pp. 524- 531 ,(2009) , 10.1016/J.JCIN.2009.04.007